DRI Healthcare Trust CEO ousted after investigation, units plunge nearly 30 per cent
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Monthly Digital Subscription
$0 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*No charge for 4 weeks then price increases to the regular rate of $19.00 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.
Monthly Digital Subscription
$4.75/week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $19 plus GST every four weeks. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $16.99 plus GST for four weeks. After four weeks, your payment will increase to $23.99 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 08/07/2024 (516 days ago), so information in it may no longer be current.
TORONTO – Units of DRI Healthcare Trust sank nearly 30 per cent after the trust removed its chief executive and suspended its chief financial officer as a result of an investigation of irregularities related to certain alleged consulting and other expenses.
DRI says the board of trustees demanded and received the immediate resignation of Behzad Khosrowshahi from the board and as CEO of the trust. Khosrowshahi also resigned as CEO of DRI Healthcare, manager of the trust.
The pharmaceutical royalty trust says Chris Anastasopoulos has also been suspended with pay as chief financial officer, pending the outcome of the investigation.
Gary Collins, chair of the board, has been appointed interim CEO of the trust, while Ali Hedayat has been named interim CEO of DRI Healthcare, manager of the trust.
Sandy Kwan has been appointed as interim chief financial officer of both the trust and DRI Healthcare.
Units in the trust closed down $4.07 at $11.17 Monday on the Toronto Stock Exchange on Monday.
This report by The Canadian Press was first published July 8, 2024.
Companies in this story: (TSX:DHT.UN)